Hafnium rapid test could enable monkeypox containment

Researchers at Pennsylvania State University have developed a rapid test for mpox based on gold and hafnium nanomaterials. This test can detect the virus within minutes, a process for which conventional tests require several days. The method utilizes plasmonic nanoparticles—particles that change their optical properties upon contact with genetic material. The resulting rapid diagnostic method can also be applied to other pathogens.

Mpox is now present in over 100 countries. The lead researcher of the rapid test study, Professor Dipanjan Pan, views rapid diagnosis as the only way to contain the disease, as therapeutics and vaccines do not provide sufficient protection.

According to Pan, by modifying the molecules of the rapid test, it could also be used to prepare for the next epidemic or even pandemic. However, the next step is to bring the test to market. To achieve this, the researchers must complete final validation and then seek commercial partners.

By the way: In addition to hafnium, germanium is also an important “medical metal” in the field of rapid diagnostics. Some time ago, we reported on a portable diagnostic device that incorporates this technology metal. (Read the article here)

Theranostics combines diagnosis and therapy. Gallium is a key metal in this field. We recently reported on three newly developed radiopharmaceutical drugs in the field of oncology. (Read the article here)

Hafnium, Gallium, and Germanium are not only three central “medical metals” but also an excellent investment opportunity. Because the medical field requires them, the value of these metals is certain to rise. For investors, this means the potential for attractive returns, including tax-free purchasing and tax-free profits after a one-year holding period.